Gastroenterology
Showing 31 of 31 topics
  A
- 
            Systemic infection from biliary obstruction; diagnose with Tokyo criteria; start broad-spectrum antibiotics and perform urgent biliary drainage (ERCP) based on severity.
- 
            Charcot triad (fever, jaundice, RUQ pain) ± hypotension/AMS suggests cholangitis. Use Tokyo Guidelines for severity grading. Start broad IV antibiotics and arrange urgent biliary drainage—ERCP preferred; percutaneous transhepatic biliary drainage if ERCP not feasible.
- 
            Systemic inflammation + cholestasis + imaging define diagnosis. Start early broad‑spectrum antibiotics and fluids; perform ERCP drainage urgently for Grade II–III disease and after stabilization for Grade I; tailor timing to sepsis severity and comorbidity.
- 
            Diagnose with 2 of 3: typical epigastric pain, lipase/amylase ≥3× ULN, or imaging; early aggressive fluids (LR), pain control, early enteral nutrition; no routine antibiotics; evaluate gallstones and triglycerides.
- 
            Diagnosis requires two of three: characteristic pain, lipase elevation, or imaging; early aggressive fluids and analgesia; early oral feeding when tolerated; manage gallstone disease and complications.
- 
            Epigastric pain radiating to the back with elevated lipase/amylase (>3× ULN) and imaging findings. Provide early goal-directed fluids (prefer lactated Ringer’s), adequate analgesia, and early enteral nutrition; avoid prophylactic antibiotics. Identify gallstone etiology and perform cholecystectomy before discharge for mild cases.
- 
            Diagnose pancreatitis with 2 of 3: characteristic pain, lipase >3× ULN, or imaging. Give early goal-directed lactated Ringer’s, adequate analgesia, and start early enteral nutrition; treat causes (gallstones, alcohol, hypertriglyceridemia). Avoid routine antibiotics unless infected necrosis is suspected.
- 
            Early care centers on LR fluids, analgesia, and early enteral nutrition; ERCP reserved for cholangitis or persistent biliary obstruction.
- 
            Hospitalize for intensive monitoring, start IV corticosteroids, perform early flexible sigmoidoscopy, and escalate to infliximab or cyclosporine if steroid-refractory; coordinate with colorectal surgery for timely colectomy when failure criteria are met.
- 
            Outpatient management focuses on fiber, topical therapies, and office procedures; escalate to surgery for refractory cases or complications.
C
- 
            Accidental or intentional ingestion of acids/alkalis causes esophageal/gastric injury. Keep NPO, avoid neutralizing/emesis/NG placement blindly, and perform early endoscopy (within 12–24 h) to grade injury; manage severe injuries in ICU with perforation surveillance and staged nutrition.
- 
            Test with tTG‑IgA and total IgA; confirm with duodenal biopsy (unless pediatric no‑biopsy criteria met). Lifelong gluten‑free diet; monitor serology, micronutrients, and bone health.
- 
            Differentiate slow‑transit constipation from pelvic floor dyssynergia; pursue anorectal testing and targeted therapy (biofeedback) before empiric laxatives alone.
D
- 
            CT confirms diagnosis; many uncomplicated cases managed outpatient sometimes without antibiotics; complicated disease needs antibiotics, drainage, or surgery.
G
- 
            Confirm delayed gastric emptying (4‑hour scintigraphy). Manage with dietary measures, glycemic control, and prokinetics; consider pyloric therapies for refractory disease.
- 
            Use an 8‑week PPI trial for typical GERD without alarms; then step‑down to lowest effective dose or on‑demand. Deprescribe PPIs when no ongoing indication; reinforce lifestyle measures.
H
- 
            Severe abdominal pain with TG >1000 mg/dL—hypertriglyceridemia‑induced acute pancreatitis (HTG‑AP).
I
- 
            Positive diagnosis using Rome IV; screen for celiac disease in IBS‑D/M; limited testing otherwise. Management combines diet (low‑FODMAP), gut‑directed pharmacotherapy, and psychological therapies.
L
- 
            Resuscitate, risk stratify, and obtain CTA for brisk bleeding when endoscopy is not immediately available; manage anticoagulants and coordinate GI and interventional radiology.
- 
            Assess hemodynamics and resuscitate; exclude brisk upper source; colonoscopy after prep for most; CTA for ongoing brisk bleeding; manage anticoagulation and target etiology.
- 
            Stabilize first; use CTA for brisk bleeding to localize; colonoscopy after prep for most; manage antithrombotics and consider IR embolization when needed.
M
- 
            Chronic watery, non‑bloody diarrhea with normal colonoscopy; diagnosis requires random biopsies. Budesonide is first‑line; review medications and bile acid malabsorption.
N
- 
            Severe pancreatitis complicated by necrosis requires early enteral nutrition, goal‑directed resuscitation, and organ support. Reserve antibiotics for proven infection. Delay intervention until walled‑off necrosis (~4 weeks) when feasible; employ a step‑up approach starting with percutaneous or endoscopic drainage and escalating to minimally invasive necrosectomy if needed.
- 
            Hematemesis or melena with hemodynamic changes suggests upper GI bleeding. Resuscitate with balanced transfusion strategy, start high-dose IV PPI, risk-stratify (GBS/Rockall), and arrange early endoscopy with endoscopic hemostasis for high-risk stigmata; resume antithrombotics per risk.
- 
            Resuscitate and risk stratify (Glasgow-Blatchford); give IV PPI, consider erythromycin pre-endoscopy; endoscopy within 24 hours with hemostasis for high-risk lesions; plan secondary prevention.
- 
            Resuscitate and risk‑stratify (Glasgow‑Blatchford). Administer high‑dose PPI and give pre‑endoscopy erythromycin when appropriate; perform early endoscopy with hemostasis. Transfuse at Hgb <7 g/dL unless exceptions; resume antiplatelets per risk/benefit.
S
- 
            Diagnose SIBO with breath testing (glucose/lactulose) or jejunal aspirate; treat with antibiotics and correct underlying motility/anatomic disorders.
U
- 
            Resuscitate and risk stratify (Glasgow-Blatchford); high-dose PPI; endoscopy within 24 h for most, sooner if unstable; endoscopic hemostasis for high-risk stigmata; test and treat H. pylori.
- 
            Nonvariceal UGIB: resuscitate, risk‑stratify (GBS/Rockall), PPI therapy, and endoscopic hemostasis within 24 h; treat H. pylori; manage antithrombotics with clear restart strategy.
- 
            Manage UGIB with ABCs, balanced transfusion targets (Hb ~7–8 g/dL), and early endoscopy (within 24 h; sooner if unstable). Use Glasgow‑Blatchford/Rockall for triage. High‑dose IV PPI for suspected non‑variceal bleeding; in suspected variceal bleeding, add octreotide and prophylactic antibiotics.
V
- 
            Resuscitate with balanced strategy, start vasoactive therapy and antibiotics, and arrange urgent endoscopy; use balloon tamponade or self expanding stent as bridge when needed.
    No topics match your filters.